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Abstract
Background: Corynebacterium pseudotuberculosis is the etiologic agent of caseous lymphadenitis (CL), a chronic
disease that affects goats and sheep. CL is characterized by the formation of granulomas in lymph nodes and other
organs, such as the lungs and liver. Current knowledge of CL pathogenesis indicates that the induction of humoral
and cellular immune responses are fundamental to disease control. The aim of this study was to evaluate the
humoral and cellular immune responses in BALB/c mice inoculated with a C. pseudotuberculosis strain isolated in
the state of Bahia, Brazil.
Results: The lymphocyte proliferation and in vitro production of IFN-γ, IL-4, IL-10, IL-12 and nitric oxide by spleen
cells stimulated with secreted and somatic antigens from the studied strain were evaluated. IgG subclasses were
also analyzed. Results showed a significant increase of Th1-profile cytokines after 60 days post-inoculation, as well
as an important humoral response, represented by high levels of IgG2a and IgG1 against C. pseudotuberculosis.
Conclusion: The T1 strain of C. pseudotuberculosis was shown to induce humoral and cellular immune responses
in BALB/c mice, but, even at a dosage of 1x107 CFU, no signs of the disease were observed.
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Background
Caseous lymphadenitis (CL) is a chronic disease caused by
Corynebacterium pseudotuberculosis that mainly affects
small ruminants. Despite the economic [1, 2] and zoonotic
[3] relevance of CL, a satisfactory vaccine model has not
been developed [4, 5].
C. pseudotuberculosis is a facultative intracellular patho-
gen that can persist inside macrophages and stimulate the
formation of granulomas [6, 7]. This species is distributed
worldwide, but has the most severe economic impacts in
Oceania, Africa and South America [8].
The pathogenesis of CL in mice was demonstrated by
monitoring the progression of lesions in the skin and
viscera of infected animals [9]. Moreover, the physi-
ology, pathogenicity and virulence mechanisms of C.
pseudotuberculosis strains have been elucidated using
genomics [8, 10], transcriptomics and proteomics method-
ologies [11, 12].
The immune response against C. pseudotuberculosis
has a well-known humoral component and involves a
complex cellular mechanism against secreted and som-
atic bacterial antigens [13–15].
The cytokines Tumor necrosis factor-α (TNF-α) and
interferon-γ (IFN-γ) are important to mount an immune
response in mice as well as sheep, whether naturally in-
fected or inoculated with C. pseudotuberculosis [16–19].
It is known that, with respect to Mycobacterium tuber-
culosis, a microorganism largely phylogenetically similar
to C. pseudotuberculosis, these cytokines play a major
role in susceptibility and regulation of associated lesions
in mice [20].
El-Enbaawy et al. (2005) [21] demonstrated that anti-
gens obtained from a C. pseudotuberculosis strain iso-
lated from a naturally infected sheep, specifically a
toxoid associated with bacterin, induce the production
of IFN-γ, as well as elicit a humoral immune response
in BALB/c mice. The present study employed a naturally
attenuated strain of C. pseudotuberculosis, denominated
T1, isolated from a granuloma taken from a goat in a rural
region of the state of Bahia, located in northeastern Brazil.
Studies previously conducted with this strain show that it
grows quickly in BHI broth medium, when compared to
other strains, but is incapable of inducing disease in goats
[22–24].
The present study characterized the immune response
in BALB/c mice, considering five animals per group,
against antigens derived from the T1 strain of C. pseudo-
tuberculosis. This murine model was chosen because of
impaired IFN-γ production in response to antigens de-
rived from M. tuberculosis, which is very closely related
to C. pseudotuberculosis [25]. The proliferation of spleen
cells was investigated, as well as the production of
cytokines, nitric oxide (NO) and serum IgG subclasses
to expand the understanding of humoral and cellular
immune responses against this strain, which may repre-
sent an ideal vaccine candidate against this disease.
Results
To determine the optimal inoculation dosage, four dif-
ferent infection dosages (5x105, 1x106, 5x106 and 1x107
CFU) of the T1 C. pseudotuberculosis strain were tested
in BALB/c mice. ELISA results showed higher IgG levels
in mice infected with the two higher dosages in com-
parison to the two lower levels tested (P < 0.001) (Fig. 1a).
No significant differences in IgG levels were seen be-
tween the groups inoculated with 5x106 and 1x107 CFU,
nor in the groups inoculated with 5x105 and 1x106 CFU.
At 120 days post-infection, none of the animals pre-
sented any evidence of lesions characteristic of the dis-
ease under clinical examination or necropsy. Because
the 1x107 CFU dosage was not observed to induce le-
sions, this experimental protocol was used to evaluate
the production of IgG subclasses and cytokines.
Fig. 1 Serum IgG immune response in mice inoculated with T1 C.
pseudotuberculosis strain, as evaluated by ELISA. Graph represents
means of Optical Density (OD) values found for each group (n = 5
animals for group). Results are representative of the mean values
obtained from two experiments. a. BALB/c mice were inoculated
with increasing dosages: 5x105, 1x106, 5x106 and 1x107 CFU. Blood
was collected 120 days after inoculation. Data were analyzed by
ANOVA and Tukey post-hoc tests; *, †, ‡ and § indicate pairs with
statistically significant differences. b. IgG subclass (IgG1, IgG2a, IgG2b
and IgG3) production throughout the course of the experiment:
control (before infection), 7, 30, 60, and 120 days after infection. Mice
were inoculated with 107 CFU of T1 strain of C. pseudotuberculosis.
Data were analyzed by ANOVA. *P < 0.05; ***P < 0.001
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Analysis of the humoral immune response against T1
C. pseudotuberculosis revealed that IgG2a production
gradually increased over time, being the predominant
IgG subclass at 120 days after infection (P < 0.001). A
significant increase in IgG1 levels (P < 0.001) was also
observed, and a discrete, yet still statistically significant,
increase of IgG2b (P < 0.05) was seen. No statistically
significant differences in IgG3 levels were detected over
the course of experimentation. Control group results are
representative of the mean OD readings obtained from
five animals before infection (Fig. 1b).
With respect to spleen cell response to antigenic stimuli,
a significant lymphoproliferative response, expressed as SI,
was observed after stimulation with secreted antigen (Se)
(p < 0.05) at 60 days post-infection in comparison to 7 and
30 days (Fig. 2). Stimulation with Se provoked a significant
difference in SI in comparison to So at 60 days after
inoculation.
In vitro production of interleukin-12 (IL-12) by spleen
cells after stimulation with So or Se antigens is shown in
Fig. 3a. Cell stimulated with both antigens had higher
IL-12 concentrations at 60 and 120 days post-infection
in comparison to controls (p < 0.05).
No differences were seen in IFN-γ concentration in the
antigen-stimulated culture supernatants in comparison to
controls at seven and 30 days post-infection, but there sig-
nificant increases were observed at 60 days (p < 0.05) and
120 days (p < 0.05) post infection. So also induced a higher
and statistical significant INF-γ production, when com-
pared to Se stimulation (Fig. 3b) at both of these times
points.
With respect to in vitro interleukin-10 (IL-10) produc-
tion, a significant statistical difference was observed in
So-stimulated cells at 60 days post-inoculation (p < 0,05)
in comparison to the previous infection times, and also
in comparison to cells stimulated with Se at this same
time point. A similar situation was observed at 120 days
after inoculation (Fig. 3c). In addition, cells stimulated
with So induced higher levels of IL-10 than Se through-
out the experiment.
Interleukin-4 (IL-4) concentrations were very low at
all experiment times evaluated with respect to both anti-
gens. However, IL-4 production by cells stimulated with
So was observed to significantly increase throughout the
course of investigation (p < 0.05), but decreased at the
120 day time point (Fig. 3d).
Nitric oxide (NO) production measured in the super-
natant of cell cultures stimulated So and Se is illustrated
in Fig. 4. A significant increase (p < 0.05) in NO levels
was seen only at 120 days post-infection in comparison
to controls.
NO production by cells stimulated with So was also ob-
served to be higher in comparison to Se, with statistical
significance (p < 0.05) at 120 days after inoculation.
Discussion
The present study found that experimental inoculations of
the attenuated T1 strain of C. pseudotuberculosis at a dos-
age of 107 CFU did not result in lesions in BALB/c mice,
even though these animals have demonstrated susceptibil-
ity to intracellular pathogens [26, 27]. Nevertheless, a
previous study has shown that a wild-type strain of C.
pseudotuberculosis was able to induce lesions at a dosage
of 102 [15].
In addition, cell cultures stimulated with T1 strain
antigens were found to induce a proliferation of spleen
cells, with secreted antigens (Se) demonstrating greater
effectiveness than somatic antigens (So) two months
after inoculation. A previous study showed that Se was
able to enhance lymphocyte proliferation in PBMCs of
an experimentally infected goat [23], which is consistent
with our results. Se was found to induce a more intense
proliferation than So due to the presence of phospholip-
ase D, an exotoxin secreted by C. pseudotuberculosis at
the beginning of infection to cleave the host cell mem-
brane [28], which may cause a preeminent proliferation of
B lymphocytes and elicit antibody production. Notably,
lymphoproliferation in a murine model after stimulus with
C. pseudotuberculosis antigens has not been described in
the literature to date.
Experimental inoculation with T1 was observed to elicit
high titers of IgG antibodies. The main IgG subclasses
produced throughout the course of infection were IgG1
and IgG2a. As C. pseudotuberculosis is an intracellular
pathogen that produces phospholipase D, an exotoxin
with highly immunogenic properties [29, 30], the produc-
tion of specific immunoglobulins is crucial to neutralize
phospholipase D.
Fig. 2 Proliferation of murine spleen cells stimulated with somatic
(So) and secreted (Se) antigens. Results express the stimulation index
(μCi) calculated from two independent experiments using splenocytes
retrieved from five non-infected (control) and five infected (inoculated)
animals from each group. Data were analyzed by ANOVA and Tukey
post-hoc tests; *P < 0.05
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In addition, the cellular immune response is another
way of reducing the dissemination of the pathogen, which
can survive and multiply inside macrophages [7, 14, 18].
Accordingly, we found a significant production of IFN-γ
by spleen cells after stimulation with So or Se C. pseudotu-
berculosis antigens two months after inoculation. This
situation was sustained until the end of the experiment
(120 days). Elevated IL-4 production was not detected,
yet, in cells stimulated with So, the production of this
cytokine was four times higher in comparison to those
stimulated with Se and controls. This phenomenon may
possibly have occurred because So has a larger amount of
structural proteins and lipid antigens than Se [31]. Relat-
edly, Lan et al. (1999) [19] found a pronounced increase
in IFN-γ production starting in the third week post-
inoculation in splenic cell cultures of ICR-JCL mice inocu-
lated with ATCC 1940 strain and stimulated with
formalin-killed bacterial cells, which was sustained until
the eighth week. In the same experiment, no significant
production of IL-4 was observed.
Fig. 3 In vitro cytokine production by murine spleen cells stimulated with somatic (So) and secreted (Se) antigens. a. Interleukin-12 (IL-12). b.
Interferon-γ (IFN-γ). c. Interleukin-10 (IL-10). d. Interleukin-4 (IL-4). Results are presented as ρg/mL, and represent the means of two independent
experiments using spleen cells retrieved from five non-infected (control) and five infected (inoculated) animals from each group. Data were
analyzed by ANOVA and Tukey post-hoc tests; *P < 0.05
Fig. 4 In vitro production of Nitric Oxide (NO) by murine spleen cells
stimulated with somatic (So) and secreted (Se) antigens. Results are
presented as ng/mL, and represent the means of two independent
experiments using spleen cells retrieved from five non-infected (control)
and five infected (inoculated) animals from each group. Data were
analyzed by ANOVA and Tukey post-hoc tests; *P< 0.05
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IL-10 and IL-12 production by spleen cells stimulated
by Se or So antigens increased post-inoculation time and
was sustained at all time points evaluated. So was found
to induce higher levels of IL-10 than Se, probably due
the structural components of So, such as cytoplasm and
membrane lipoproteins [31].
IL-10 may control IFN-γ synthesis during infection,
thereby avoiding Th1 over-reactivity [32]. On the other
hand, IL-12 can also trigger mechanisms related to cell
proliferation and IFN-γ production [33]. Some studies
have showed that IFN-γ, IL-10 and IL-12 are required to
control persistent infections caused by intracellular
parasites [34–36]. IL-12 is a cytokine crucial to Th1 shift,
which is required to prevent the dissemination of patho-
gens within the host in order to control infection by facul-
tative intracellular bacteria, such as C. pseudotuberculosis
[14]. Accordingly, we found increased IL-12 production
after 60 days, probably resulting from an immune re-
sponse to reduce bacterial proliferation. Higher levels of
IL-12 were detected at 120 days for both So and Se anti-
gens, probably due to the persistence of infection. It is
possible that, after this time, these levels would decrease
as a result of IL-10 production.
NO production was also evaluated, due to its effective-
ness in regulating the growth of intracellular pathogens
[37]. Proteomic analysis has identified NO-responsive
extracellular proteins of C. pseudotuberculosis and it also
demonstrated the participation of the extracytoplasmic
function sigma factor σE in composition of C. pseudotu-
berculosis exoproteome [38]. In the present studt, while
NO production by spleen cells stimulated with So and
Se antigens was higher at 120 days post-infection, So re-
sulted in higher proliferations than Se, in accordance to
what was observed in IFN-γ and IL-10 production.
Conclusion
The attenuated T1 strain of C. pseudotuberculosis was
found to induce both humoral and cellular immune re-
sponses in an experimental model of susceptible BALB/c
mice. A 107 CFU dosage did not result in any lesions in
the mice evaluated. As the present study has demon-
strated that, in addition to the production of antibodies,
an efficient cellular response is important to the control
of CL, the T1 strain can be considered as a promising
option for potential vaccine candidates.
Methods
Bacterial strain
The T1 strain of C. pseudotuberculosis was isolated
from granulomas obtained from goats raised in the mu-
nicipality of Juazeiro, located in the state of Bahia in
northeastern Brazil. Isolates were stored in the Depart-
ment of Microbiology collection center at the Health
Sciences Institute of the Federal University of Bahia
(ICS - UFBA).
The identification of the T1 strain was confirmed by
several microbiological methods: Gram staining, colony
morphology, synergistic hemolytic (CAMP) reactions
with Rhodococcus equi, urease and catalase production,
as well as glucose and maltose fermentation. A commer-
cial kit was used to aid in identification (API Coryne -
BioMérieux, Merci l’Etoile, France). Since the T1 strain
demonstrated a less severe pattern of hemolysis during
synergistic hemolysis testing in comparison to other wild
strains, other authors have suggested its use as a vaccinal
strain [39].
The T1 strain was cultivated in Brain/Heart Infusion
(BHI) broth and incubated for 72 h at 37 °C. The bacterial
suspension was washed in Phosphate Buffer Saline (PBS)
and centrifuged for 30 min at 3,000 g at 4 ° C.
Somatic antigen (So)
The bacterial pellet was homogenized in PBS (pH 7.4)
and sonicated at 60 Hz under 4 °C for five cycles lasting
60 s each (Branson Sonifier 450, Branson, Dunbury, CT,
USA). The sample was centrifuged for 30 min at 10,000
g and, after collection, the supernatant was stored at
-20 °C in aliquots until use. Protein concentration was
determined by Lowry’s modified method using a Bio-Rad
Protein Assay (Bio-Rad, Hercules, CA, USA).
Secreted antigen (Se)
Se was obtained from the culture supernatant by satur-
ation with 30 % ammonium sulfate (HCl) pH 4.0 and n-
butanol under slow agitation at room temperature. The
sample was homogenized, left undisturbed for 60 min,
and then centrifuged for 10 min at 1,350 g under 4 ° C.
The resulting interphase was dissolved in 20 mM of Tris
buffer pH 7.4 (500 μL of buffer to 5 mL of culture super-
natant), followed by dialysis in 50 mM Phosphate buffer
pH 7.4 for 48 h. The sample was concentrated by ultra-
filtration with a 10 kDa membrane (Millipore, Billerica,
MA, USA). Protein concentration was determined by
Lowry’s modified method using a Bio-Rad Protein Assay
(Bio-Rad, Hercules, CA, USA).
Inoculation protocol and experimental design
Prior to experimental inoculation, an optimal inocula-
tion dose experiment was performed to obtain max-
imum antibody production. Eight-week-old male and
female BALB/c mice, provided by the Experimental
Animal Facility at the Gonçalo Moniz Research Center,
Oswaldo Cruz Foundation, Salvador, Bahia-Brazil, were
used to establish the inoculation protocol. The optimal
dose was determined using five groups of five mice.
Four groups received an intraperitoneal inoculation of
5x105,106, 5x106 and 107 colony forming units (CFU) of
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C. pseudotuberculosis T1 strain diluted in sterile PBS at
a final volume of 1 mL. The control group received
1 mL of sterile PBS by intraperitoneal inoculation.
Blood was collected from the tail vein and the animals
used for dosage experimentation were euthanized in a
CO2 chamber. ELISA was performed 120 days after in-
oculation to evaluate humoral immune response by
identifying the highest levels of IgG and its subclasses.
After determining the optimal inoculation dosage,
male and female BALB/c mice received intraperitoneal
inoculations with 107 CFU/mL of T1 strain in 1 mL of
sterile PBS, while the control group was inoculated with
1 mL of sterile PBS. After blood sampling from the tail
vein, five animals from each group were euthanized in a
CO2 chamber at 7, 30, 60 and 120 days after receiving
inoculation. The animals’ spleens were removed for sple-
nocyte isolation in order to perform in vitro lymphocyte
proliferation and cytokine production assays. Blood was
also collected for immunoglobulin analysis.
Indirect ELISA for analysis of IgG and its isotypes
ELISA plates (Costar, Corning Life Sciences, Lowell,
MA, USA) were coated with So (1 μg in 100 μL of
50 mM Carbonate-bicarbonate buffer pH 9.6, in each
well), incubated overnight at 4 oC and washed twice in
0.05 % PBS Tween-20 (PBS-T). Plates were then blocked
with 200 μL of 5 % skim milk in 0.05 % PBS-T and incu-
bated for 2 h at 37 oC. Next, the plates were washed
once with PBS-T and 50 μL of diluted serum (1:50 in
1 % skim milk/PBS-T) was added to each well. Plates
were then incubated for 1 h at 37 °C and washed five
times with PBS-T. Next, wells were filled with 50 μL/
well of HRP conjugated rabbit Ig antimouse IgG (Sigma-
Aldrich, St Louis, MO, USA) at a dilution of 1:10,000 in
1 % skim milk/PBS-T to assess total IgG. To evaluate
IgG1, IgG2a, IgG2b and IgG3, wells were filled with
50 μL/well of HRP conjugated rabbit Ig antimouse IgG1,
IgG2a, IgG2b or IgG3 (Zymed, San Francisco, CA,
USA), respectively, each diluted at 1:8.000 in 1 % skim
milk/PBS-T. All plates were then incubated for 45 min
at 37 oC. Each plate was washed five times in PBS-T and
50 μL/well of Citrate Phosphate Buffer pH 5.1, ortho-
phenyl-diamine (Sigma, St Louis, MO, USA) and 30 %
H2O2] were added and left for 15 min at room
temperature in a dark chamber. Reactions were stopped
with 25 μL/well of 4 N H2SO4 and Optical Density (OD)
was measured at 490 nm using an ELISA Plate Reader
(BIORAD, Hercules, CA, USA).
Lymphocyte proliferation assay
The spleen of each mouse was removed, washed three
times with Hanks’ solution, and then placed in a petri
dish containing 5 mL of RPMI 1640 medium (Gibco
Laboratories, North Andover, MA, USA) supplemented
with penicillin and streptomycin. The spleens were then
macerated and the cellular suspension was transferred to
a conical tube containing 5 mL of the same medium,
followed by centrifugation at 400 g for 3 min. Pellets were
resuspended in 0.17 M of NH4Cl for 5 min at 4 °C in
order to lyse erythrocytes. Cells were washed 3 times with
RPMI and then resuspended in RPMI enriched with 10 %
bovine fetal serum.
Cell viability was determined by a Trypan Blue exclu-
sion assay. 106 cells/mL were cultivated in 96-well mi-
croculture plates in RPMI-1640 medium supplemented
with L-glutamine, penicillin/streptomycin, gentamicin
and 10 % fetal calf serum. Cells were stimulated by So or
Se C. pseudotuberculosis antigens (40 μg/mL), and poke-
weed mitogen (2.5 μg/mL) was used as a positive con-
trol, while medium alone was used as a negative control.
All plates were incubated for 120 h at 37o C under 5 %
CO2. 1 μBq/well (10 μL) of fresh [
3H] thymidine (GE
Healthcare, Bucks, UK) was added 18 h prior to the end
of the incubation time using a beta counter system (iMatic
Canberra, Meriden, USA). After 120 h, plates were frozen
at -20 oC and β-radiation was measured as described by
Paule et al. (2004) [23]. Results are expressed in terms of a
Stimulation Index (SI), calculated by dividing the β-
radiation found for each stimulated sample by the radi-
ation measured from its respective negative control.
ELISA for cytokines quantification
Cytokine analysis was performed in a culture supernatant
obtained from cells (106/mL) cultivated in the same
medium used for lymphoproliferation assay. Spleen cells
were stimulated with So and Se C. pseudotuberculosis
antigens (40 μg/mL), pokeweed mitogen (2,5 μg/mL) as a
positive control, and the medium alone (negative control).
The plates were incubated for 120 h at 37o C in 5 % CO2
[40]. The supernatant was collected, centrifuged, and kept
at -20o C until use.
Cytokine profile analysis was performed using com-
mercial kits for IFN-γ and IL-10 (R&D Systems, Minne-
apolis, MN, USA), and IL-12 and IL-4 (Pharmigen, San
Jose, CA, USA) according to the manufacturer instruc-
tions. Results are expressed in ρg/mL.
Nitric oxide (NO) production assay
The presence of NO in the supernatant of spleen cells
cultures that were incubated for 120 h was measured
by nitrite assay, based on Griess reaction [41]. Briefly,
supernatant (50 μL) was mixed with 50 μL of Griess re-
agent (1 % sulfanilamide and 0.1 % N-(1-naphthyl)ethyle-
nediamine, in 5 % phosphoric acid) and incubated for
10 min at room temperature. Absorbances were measured
at 492 ηm using an ELISA microplate reader (BioRad,
Hercules, CA, USA). The standard curve of NO2
− was
prepared by diluting nitrite stock solution (1 M NaNO2
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diluted in Milli-Q water) in spleen cell culture media.
Results are expressed in ηg/mL.
Statistical analysis
For determination of statistical significance between ex-
perimental groups at an individual time-point, a ana-
lysis of variance (ANOVA) was performed using SPSS
12.0. (IBM Statistics, Chicago, EUA). A p value of <0.05
was considered significant.
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